154 related articles for article (PubMed ID: 11527091)
1. Is there a medical need to explore the clinical use of insulin-like growth factor I?
Savage MO; Camacho-Hübner C; Dunger DB; Ranke MB; Ross RJ; Rosenfeld RG
Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S65-9. PubMed ID: 11527091
[TBL] [Abstract][Full Text] [Related]
2. Mecasermin (recombinant human insulin-like growth factor I).
Rosenbloom AL
Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
[TBL] [Abstract][Full Text] [Related]
3. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
Drugs R D; 2005; 6(2):120-7. PubMed ID: 15777106
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone insensitivity syndromes: a preliminary report on changes in insulin-like growth factors and their binding proteins during treatment with recombinant insulin-like growth factor I. Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
Blum WF; Hall K; Ranke MB; Wilton P
Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():15-9. PubMed ID: 7693071
[TBL] [Abstract][Full Text] [Related]
5. Treatment of growth hormone insensitivity syndrome (GHIS) with insulin-like growth factor (IGF-I).
Ranke MB
Baillieres Clin Endocrinol Metab; 1996 Jul; 10(3):401-10. PubMed ID: 8853447
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I deficiency caused by a partial deletion of the IGF-I gene: effects of rhIGF-I therapy.
Camacho-Hübner C; Woods KA; Miraki-Moud F; Clark A; Savage MO
Growth Horm IGF Res; 1999 Jun; 9 Suppl B():47-51; discussion 51-2. PubMed ID: 10549306
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options.
Kemp SF
BioDrugs; 2009; 23(3):155-63. PubMed ID: 19627167
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism.
Nakae J; Kato M; Murashita M; Shinohara N; Tajima T; Fujieda K
J Clin Endocrinol Metab; 1998 Feb; 83(2):542-9. PubMed ID: 9467572
[TBL] [Abstract][Full Text] [Related]
9. Serum profiles of insulin-like growth factors and their binding proteins in adults with growth hormone receptor deficiency treated with insulin-like growth factor I.
Fielder PJ; Gargosky SE; Vaccarello M; Wilson K; Cohen P; Diamond F; Guevara-Aguirre J; Rosenbloom AL; Rosenfeld RG
Acta Paediatr Suppl; 1993 Mar; 388():40-3; discussion 44. PubMed ID: 7687170
[TBL] [Abstract][Full Text] [Related]
10. IGF-I therapy in growth disorders.
Rosenfeld RG
Eur J Endocrinol; 2007 Aug; 157 Suppl 1():S57-60. PubMed ID: 17785699
[TBL] [Abstract][Full Text] [Related]
11. Ovarian expression of insulin-like growth factor-I (IGF-I), IGF binding proteins, and growth hormone (GH) receptor in heifers actively immunized against GH-releasing factors.
Cohick WS; Armstrong JD; Whitacre MD; Lucy MC; Harvey RW; Campbell RM
Endocrinology; 1996 May; 137(5):1670-7. PubMed ID: 8612500
[TBL] [Abstract][Full Text] [Related]
12. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
Camacho-Hübner C; Woods KA; Miraki-Moud F; Hindmarsh PC; Clark AJ; Hansson Y; Johnston A; Baxter RC; Savage MO
J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of mecasermin rinfabate.
Kemp SF; Fowlkes JL; Thrailkill KM
Expert Opin Biol Ther; 2006 May; 6(5):533-8. PubMed ID: 16610982
[TBL] [Abstract][Full Text] [Related]
14. Effects of growth hormone and pregnancy on expression of growth hormone receptor, insulin-like growth factor-I, and insulin-like growth factor binding protein-2 and -3 genes in bovine uterus, ovary, and oviduct.
Kirby CJ; Thatcher WW; Collier RJ; Simmen FA; Lucy MC
Biol Reprod; 1996 Nov; 55(5):996-1002. PubMed ID: 8902209
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-I (rhIGF-I) therapy of short stature.
Rosenbloom AL
J Pediatr Endocrinol Metab; 2008 Apr; 21(4):301-15. PubMed ID: 18556960
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
Ranke MB
Trends Endocrinol Metab; 2005; 16(4):190-7. PubMed ID: 15860416
[TBL] [Abstract][Full Text] [Related]
17. Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome--a clinical research center study. GHIS Collaborative Group.
Backeljauw PF; Underwood LE
J Clin Endocrinol Metab; 1996 Sep; 81(9):3312-7. PubMed ID: 8784089
[TBL] [Abstract][Full Text] [Related]
18. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
[TBL] [Abstract][Full Text] [Related]
19. Impaired growth in Rabson-Mendenhall syndrome: lack of effect of growth hormone and insulin-like growth factor-I.
Longo N; Singh R; Griffin LD; Langley SD; Parks JS; Elsas LJ
J Clin Endocrinol Metab; 1994 Sep; 79(3):799-805. PubMed ID: 8077364
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis.
Boonen S; Mohan S; Dequeker J; Aerssens J; Vanderschueren D; Verbeke G; Broos P; Bouillon R; Baylink DJ
J Bone Miner Res; 1999 Dec; 14(12):2150-8. PubMed ID: 10620075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]